leukemias - Viral Trends
Medical Xpress: Hidden nuclear droplets link multiple leukemias and reveal a new therapeutic target Hidden nuclear droplets link multiple leukemias and reveal a new therapeutic target A novel treatment for leukemias and lymphomas that arise from immune system T cells was found to be effective at killing these cancers in mice bearing human T-cell tumors. A novel treatment for ... EurekAlert!: Targeting menin induces responses in acute leukemias with KMT2A rearrangements or NPM1 mutations Targeting menin induces responses in acute leukemias with KMT2A rearrangements or NPM1 mutations ascopubs.org: Are Pivotal Clinical Trials for Drugs Approved for Leukemias and Multiple Myeloma Representative of the Population at Risk?
Understanding the Context
Are Pivotal Clinical Trials for Drugs Approved for Leukemias and Multiple Myeloma Representative of the Population at Risk? The American Journal of Managed Care: Expertise Is Essential to Bispecific Access for Patients With Acute Leukemias: Amir Fathi, MD Expertise Is Essential to Bispecific Access for Patients With Acute Leukemias: Amir Fathi, MD Healio: Menin inhibitors emerge as potential new treatment option for advanced acute leukemias Menin inhibitors emerge as potential new treatment option for advanced acute leukemias Circumstantial and direct evidence, including a review of twin and backtracking studies, demonstrate potential prenatal development of acute childhood leukemias. Acute lymphoblastic leukemia (ALL) and ... The FDA has extended the deadline to review Orca-T for the treatment of myelodsyplastic syndromes and acute leukemias with a PDUFA date of .